Status:
UNKNOWN
The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis
Lead Sponsor:
University of Cyprus
Collaborating Sponsors:
World Olive Center for Health
Ellis-Farm, Eliama Daily Value
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This is an open label feasibility trial to examine the effect of a complementary treatment with High Phenolic Extra Virgin Olive Oil (HPEVOO) on the cognitive and mental health of people with Multiple...
Eligibility Criteria
Inclusion
- Clinical diagnosis of MS
- Must be between 18 to 65 years of age
- Both males and females are eligible for participation
- Must have at least five years of education
- Must be fluent in Greek language
Exclusion
- Other neurological, psychiatric or chronic condition
- Enrollment in other trials/drug studies
- Experiencing side effects from previous treatments
- Inadequate visual and auditory acuity
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04787497
Start Date
May 1 2022
End Date
September 1 2024
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private medical office
Thessaloniki, Greece